Perrigo Reports Second Quarter 2026 Financial Results From Continuing Operations
Perrigo reported Q2 2026 net sales of $1.02 billion, down 3.2% year-over-year, while reported diluted EPS rose to $0.63 from $0.00 in the prior year due to a gain on the Dermacosmetics divestiture. Underlying business performance was softer, with adjusted EPS declining 12.3% to $0.50 and core revenue falling 3.1% amid ongoing category softness and unfavorable mix.
Key figures
- Eps
- 0.63
- Revenue
- 1023000000
- Guidance
- FY2026 Adjusted EPS $2.00 to $2.30
- Revenue Yoy
- -3.2%
- Adjusted eps
- 0.5
- Core revenue
- 907000000
- Adjusted eps yoy
- -12.3%
- Adjusted operating margin
- 12.2%
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.